BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23021156)

  • 1. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
    Bosco JL; Halpenny B; Berry DL
    Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer.
    Berry DL; Halpenny B; Wolpin S; Davison BJ; Ellis WJ; Lober WB; McReynolds J; Wulff J
    J Med Internet Res; 2010 Dec; 12(4):e67. PubMed ID: 21169159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.
    Berry DL; Halpenny B; Hong F; Wolpin S; Lober WB; Russell KJ; Ellis WJ; Govindarajulu U; Bosco J; Davison BJ; Bennett G; Terris MK; Barsevick A; Lin DW; Yang CC; Swanson G
    Urol Oncol; 2013 Oct; 31(7):1012-21. PubMed ID: 22153756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials.
    Trinh QD; Hong F; Halpenny B; Epstein M; Berry DL
    Urol Oncol; 2020 Mar; 38(3):78.e7-78.e13. PubMed ID: 31883873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision support for men with prostate cancer: Concordance between treatment choice and tumor risk.
    Filson CP; Hong F; Xiong N; Pozzar R; Halpenny B; Berry DL
    Cancer; 2021 Jan; 127(2):203-208. PubMed ID: 33119142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer.
    Berry DL; Wang Q; Halpenny B; Hong F
    Patient Educ Couns; 2012 Aug; 88(2):262-7. PubMed ID: 22608696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.
    Berry DL; Hong F; Blonquist TM; Halpenny B; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M; Somayaji P
    J Urol; 2018 Jan; 199(1):89-97. PubMed ID: 28754540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer.
    Underhill ML; Hong F; Berry DL
    Health Qual Life Outcomes; 2014 Oct; 12():159. PubMed ID: 25344101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
    Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M
    Urol Oncol; 2021 Aug; 39(8):493.e9-493.e15. PubMed ID: 33353864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer.
    Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ
    Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Impact of Decision Aid Use on Post Prostatectomy Patient Reported Outcomes.
    Lane GI; Qi J; Dupati A; Ferrante S; Dunn RL; Paudel R; Wittmann D; Wallner LP; Berry DL; Ellimoottil C; Montie JE; Clemens JQ;
    Urology; 2022 Jul; 165():187-192. PubMed ID: 35219768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.
    van Tol-Geerdink JJ; Willem Leer J; Weijerman PC; van Oort IM; Vergunst H; van Lin EN; Alfred Witjes J; Stalmeier PF
    BJU Int; 2013 Apr; 111(4):564-73. PubMed ID: 22882966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating preferences for treatments in patients with localized prostate cancer.
    Ávila M; Becerra V; Guedea F; Suárez JF; Fernandez P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Cunillera O; Pardo Y; Cots F; Ferrer M;
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):277-87. PubMed ID: 25491504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions.
    Pozzar RA; Xiong N; Hong F; Filson CP; Chang P; Halpenny B; Berry DL
    BMC Med Inform Decis Mak; 2022 Aug; 22(1):223. PubMed ID: 36002847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.
    Wilson LS; Blonquist TM; Hong F; Halpenny B; Wolpin S; Chang P; Filson CP; Master VA; Sanda MG; Chien GW; Jones RA; Krupski TL; Berry DL
    BMC Med Inform Decis Mak; 2019 Jan; 19(1):6. PubMed ID: 30626400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of long-term functional outcomes after prostate cancer treatment.
    Carlsson S; Drevin L; Loeb S; Widmark A; Lissbrant IF; Robinson D; Johansson E; Stattin P; Fransson P
    BJU Int; 2016 Jun; 117(6B):E36-45. PubMed ID: 25959859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
    Xu J; Janisse J; Goodman M
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.
    Hall JD; Boyd JC; Lippert MC; Theodorescu D
    Urology; 2003 Feb; 61(2):402-7. PubMed ID: 12597956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usability evaluation and adaptation of the e-health Personal Patient Profile-Prostate decision aid for Spanish-speaking Latino men.
    Berry DL; Halpenny B; Bosco JLF; Bruyere J; Sanda MG
    BMC Med Inform Decis Mak; 2015 Jul; 15():56. PubMed ID: 26204920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.